来源：2024 ASCO Breakthrough官网
2024年美国临床肿瘤学会突破峰会（ASCO Breakthrough）将于8月8-10日在日本横滨举行。本届峰会以"点亮癌症治疗的提升之路（Shining a Light on Advances in Cancer Care）"为主题，旨在汇聚肿瘤学领域的领军人物和创新者，共同探讨和分享最新的研究成果与技术革新。近日，官网已公布摘要标题，具体摘要内容将于8月7日早上5点（北京时间）公布。【肿瘤资讯】整理了
乳腺癌
相关的研究题目，以飨读者。
正在进行的试验——壁报专场B
Trials in Progress Poster Session B
摘要号:
TPS22
壁报编号：L1
OPERA-01：一项随机、开放标签、3期研究，评估palazestrant（OP-1250） vs 标准治疗在内分泌治疗和CDK4/6抑制剂治疗失败后的ER+、HER2-晚期或转移性乳腺癌患者中的疗效
OPERA-01: A randomized, open-label, phase 3 study of palazestrant (OP-1250) vs standard-of-care for patients with ER+, HER2- advanced or metastatic breast cancer after endocrine therapy and CDK4/6 inhibitors.
讲者: Joohyuk Sohn, MD, PhD
摘要号:2
壁报编号：A1
1b期研究中抗TROP2 ADC ESG401在一线转移性TNBC治疗中的疗效结果更新
Updated efficacy of anti-TROP2 ADC ESG401 for first-line metastatic TNBC in phase 1b study.
讲者: Xiaoyan Xing, MD, PhD | Shanghai Escugen Biotechnology Co., Ltd.
摘要号: 3
壁报编号：A2
一种用于在新辅助化疗期间早期预测乳腺癌退缩模式的人工智能系统
An artificial intelligence system for early prediction of breast cancer regression pattern during neoadjuvant chemotherapy.
讲者: Yuhong Huang
摘要号: 4
壁报编号：A3
使用机器学习对乳腺癌转移进行预测分析并识别遗传标志物
Predictive analysis of breast cancer metastasis and identification of genetic markers using machine learning.
讲者: Kovuri Umadevi, MD DNB
摘要号: 5
壁报编号：A4
评价肿瘤培养的血小板和肿瘤干细胞对乳腺癌亚型的相互作用
Evaluating interaction between tumor educated platelets and cancer stem cells on breast cancer subtypes.
讲者: Aishwarya Guha, MSc, BSc
摘要号: 6
壁报编号：A5
通过增强的LC3-p62-NRF2反馈回路研究自噬通量受损对乳腺癌发生的影响
Effect of impaired autophagic flux on breast carcinogenesis through the enhanced LC3-p62-NRF2 feedback loop.
讲者: Mehreen Aftab, PhD
摘要号: 7
壁报编号：A6
利用甲基化和片段组学分析血浆细胞游离DNA，区分良性和恶性乳腺肿瘤
Multimodal analysis of methylation and fragmentomic profiles in plasma cell free DNA for differentiation of benign and malignant breast tumors.
讲者: Thi Tuong Vi Van, BSc | Medical Genetics Institute
摘要号: 8
壁报编号：A7
中国县域地区乳腺癌诊疗能力现状研究与分析
Research and analysis on the situation of diagnosis and treatment capabilities of breast cancer in China county.
讲者: Xiang Tan
摘要号: 9
壁报编号：A8
研究他莫昔芬-RACK7/KDM5C-IFN-I轴对ER+乳腺癌免疫调节的影响
Investigation of a tamoxifen-RACK7/KDM5C-IFN-I axis for ER+ breast cancer immunomodulation.
讲者: Marvin Angelo Esteban Aberin, BS | Taiwan International Graduate Program in Molecular Medicine, Institute of Biomedical Sciences, Academia Sinica and National Yang Ming Chiao Tung University
摘要号: 10
壁报编号：A9
巨噬细胞和上皮细胞相互作用在不同亚型乳腺癌进展中的影响
Investigation of the effect of macrophage and epithelial cell interaction in the progression of different subtypes of breast cancer.
讲者: Banani Majumdar, MSc | The University of Burdwan
摘要号: 11
壁报编号：A10
大型区域综合医院乳腺癌术后乳房重建的患者报告结局
Patient reported outcome measures at a large district general hospital post-mastectomy and implant based reconstruction.
讲者: Danny Fraser, MBBS
摘要号: 12
壁报编号：B1
利用PET-CT评估乳腺癌患者对新辅助化疗的反应
Utility of PET-CT for assessment of response to neo-adjuvant chemotherapy in breast cancer.
讲者:Deepthi Valiyaveettil, MD, MBBS
摘要号: 13
壁报编号：B2
曲妥珠单抗+帕妥珠单抗+氟维司群新辅助治疗HER2阳性、ER阳性早期乳腺癌老年患者
Neoadjuvant treatment with trastuzumab and pertuzumab plus fulvestrant in older patients with HER2-positive, ER-positive early breast cancer.
讲者: Juan Jose Celis, MD
摘要号: 14
壁报编号：B
3
3D细胞培养中雌激素受体突变乳腺癌的特征
Characterization of estrogen receptor mutant breast cancer in 3D cell culture.
讲者:Olivia Mayer, BS
摘要号: 15
壁报编号：B4
评估I-III期HR或ER阳性乳腺癌肥胖患者在接受芳香化酶抑制剂治疗后，多模式减重计划对复发率的影响
